Health Care Equipment & Supplies · NYSE

STESTERIS plc

Last close
$264.32 +4.3%
52-week range
$195.14 to $269.44
Market cap
$25.7B
Next earnings
Not scheduled

Fiscal 2026 at a glance

Revenue
$5.94B
+9% vs FY25
Net income
$782M
+27% vs FY25
Free cash flow
$972M
+25% vs FY25
Net cash
-$1.49B
Cash $440M, debt $1.93B

Stock price

+293% since Dec 2016

Valuation vs its own history since 2018

Below its median since 2018 on all 4 multiples

Where each multiple sits today inside its own range since 2018, measured at every quarter end. The thin tick is the median.

P/E, trailing
31.4x
24.9x184x
16th percentile, below its median of 37.6x
Positive-earnings quarters only
Price / sales
4.2x
3.3x5.8x
34th percentile, below its median of 4.3x
EV / EBITDA
16.2x
12.9x32.1x
16th percentile, below its median of 18.7x
Price / free cash flow
27.4x
21.9x61.3x
23rd percentile, below its median of 36.5x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
31.4x
Earnings yield
3.2%
Price / sales
4.2x
Price / book
3.5x
Price / operating cash flow
19.9x
EV / EBITDA
16.2x
EV / sales
4.4x
Free cash flow yield
3.7%

Profitability

Gross margin
44.6%
Operating margin
19.0%
Net margin
13.4%
Return on equity
11.4%
Return on capital
9.4%

Growth per year

Revenue, 3 years
+9.4%
Revenue, 5 years
+13.8%
Revenue, 9 years
+9.5%
EPS, 3 years
+95.0%

Balance sheet

Cash and investments
$531M
Total debt
$1.89B
Net cash
-$1.36B
Debt / equity
0.26x
Current ratio
2.05x

Shares and dividend

Shares outstanding
97.1M
Share count, 5 years
+14.9%
Beta, 1 year
0.41
Dividend yield
1.0%
Dividend per share, TTM
$2.58
Payout ratio
30.5%

Ten years of the business

Last 38 quarters, fiscal 2017 to 2026 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $1.59B
RevenueNet income
Gross profitLatest quarter $711M
EBITDALatest quarter $420M
Margins45 / 19 / 13%
GrossOperatingNet
Earnings per shareLatest quarter $2.19
Cash flowLatest quarter $289M
OperatingCapexFree
Cash vs debtLatest quarter $531M
Cash and investmentsTotal debt
P/E historyNow 31.4x
P/E, median 37.6x dashed
P/S historyNow 4.2x
P/S, median 4.3x dashed

Where the revenue comes from

Services went from 48% to 48% of revenue in 3 years

Share of revenue by product line, fiscal 2023 to 2026, as reported in the 10-K.

ProductServices
FY23
52%48%
$4.54B
FY24
54%46%
$5.14B
FY25
53%47%
$5.46B
FY26
52%48%
$5.94B
Fiscal 2026 by product line
Product lineRevenueSharevs FY25
Product$3.06B51.6%+7%
Services$2.88B48.4%+11%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
STE STERIS plc $25.7B +8% 19.0%31.4x4.2x 16th percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
Founded
1985
Headquarters
Dublin, Ireland
Fiscal year ends
March
Website
steris.com

What it does

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about STE.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 543 active funds. Crowd level: quiet.

Open the Smart money tab